Robin Kramer
Chief Financial Officer at Biogen Inc. (BIIB)
Robin Kramer has filed 32 insider reports with the SEC since February 2021, as director at Armata Pharmaceuticals, Inc. (ARMP) and chief Financial Officer at Biogen Inc. (BIIB). The latest filing, on March 12, 2026, reports grant or award at Armata Pharmaceuticals, Inc. (ARMP).
- Filings
- 32
- Companies
- 2
- Bought on market
- None
- Sold on market
- None
Companies where Robin Kramer is an insider
| Company | Role | Shares held | Bought | Sold | Avg buy | Price now | Last filing |
|---|---|---|---|---|---|---|---|
| Director | $3.17 | Mar 12, 2026 | |||||
| Chief Financial Officer | 11,472 | $251.41 | Feb 18, 2026 |
Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.
Every filing
- Mar 9, 2026ARMPSEC Form 4 filed by Director Kramer RobinForm 4Grant or award
- Feb 13, 2026BIIBSEC Form 4 filed by Chief Financial Officer Kramer RobinForm 4Grant or award
- Feb 6, 2026BIIBChief Financial Officer Kramer Robin converted options into 5,003 shares and covered exercise/tax liability with 1,543 shares, increasing direct ownership by 43% to 11,472 unitsForm 4Shares withheld for taxes or exercise priceExercise or conversion of a derivative
- Feb 10, 2025BIIBChief Accounting Officer Kramer Robin converted options into 834 shares and covered exercise/tax liability with 245 shares, increasing direct ownership by 8% to 8,012 unitsForm 4Shares withheld for taxes or exercise priceExercise or conversion of a derivative
- Feb 7, 2025BIIBChief Accounting Officer Kramer Robin converted options into 1,491 shares and covered exercise/tax liability with 476 shares, increasing direct ownership by 16% to 7,423 unitsForm 4Grant or awardShares withheld for taxes or exercise priceExercise or conversion of a derivative
- Feb 5, 2025ARMPSEC Form 4 filed by Director Kramer RobinForm 4Grant or award
- Dec 6, 2024BIIBChief Accounting Officer Kramer Robin converted options into 351 shares and covered exercise/tax liability with 170 shares, increasing direct ownership by 3% to 6,408 unitsForm 4Shares withheld for taxes or exercise priceExercise or conversion of a derivative
- Mar 14, 2024ARMPSEC Form 4 filed by Kramer RobinForm 4Grant or award
- Feb 16, 2024BIIBKramer Robin converted options into 1,345 shares and covered exercise/tax liability with 396 shares, increasing direct ownership by 18% to 6,227 unitsForm 4Shares withheld for taxes or exercise priceOther acquisition or dispositionExercise or conversion of a derivative
- Feb 9, 2024BIIBKramer Robin converted options into 833 shares and covered exercise/tax liability with 245 shares, increasing direct ownership by 13% to 5,278 unitsForm 4Shares withheld for taxes or exercise priceExercise or conversion of a derivative
- Feb 8, 2024BIIBKramer Robin converted options into 788 shares and covered exercise/tax liability with 253 shares, increasing direct ownership by 13% to 4,690 unitsForm 4Grant or awardShares withheld for taxes or exercise priceExercise or conversion of a derivative
- Jan 29, 2024BIIBSEC Form 4 filed by Kramer RobinForm 4Grant or award
- Dec 21, 2023ARMPSEC Form 4 filed by Kramer RobinForm 4Grant or award
- Dec 8, 2023BIIBKramer Robin converted options into 351 shares and covered exercise/tax liability with 170 shares, increasing direct ownership by 5% to 4,155 unitsForm 4Shares withheld for taxes or exercise priceExercise or conversion of a derivative
- Jun 30, 2023BIIBSEC Form 4 filed by Kramer RobinForm 4Shares withheld for taxes or exercise priceExercise or conversion of a derivative
- Feb 17, 2023BIIBSEC Form 4: Kramer Robin converted options into 512 shares and covered exercise/tax liability with 238 sharesForm 4Shares withheld for taxes or exercise priceOther acquisition or dispositionExercise or conversion of a derivative
- Feb 10, 2023BIIBSEC Form 4: Kramer Robin covered exercise/tax liability with 590 shares and converted options into 1,061 shares, increasing direct ownership by 15% to 3,570 units (for withholding tax)Form 4Shares withheld for taxes or exercise priceOther acquisition or dispositionExercise or conversion of a derivative
- Feb 8, 2023BIIBSEC Form 4 filed by Kramer RobinForm 4Grant or award
- Jan 25, 2023BIIBSEC Form 4: Kramer Robin was granted 887 shares, increasing direct ownership by 40% to 3,099 unitsForm 4Grant or award
- Dec 8, 2022BIIBSEC Form 4: Kramer Robin converted options into 350 shares and covered exercise/tax liability with 156 shares, increasing direct ownership by 10% to 2,212 unitsForm 4Shares withheld for taxes or exercise priceExercise or conversion of a derivative
- Jul 1, 2022BIIBSEC Form 4: Kramer Robin converted options into 252 shares and covered exercise/tax liability with 74 shares, increasing direct ownership by 10% to 2,018 unitsForm 4Shares withheld for taxes or exercise priceExercise or conversion of a derivative
- Apr 13, 2022ARMPSEC Form 4 filed by Kramer RobinForm 4Grant or award
- Feb 18, 2022BIIBSEC Form 4: Kramer Robin converted options into 396 shares and covered exercise/tax liability with 117 shares, increasing direct ownership by 19% to 1,737 unitsForm 4Shares withheld for taxes or exercise priceOther acquisition or dispositionExercise or conversion of a derivative
- Feb 12, 2022BIIBSEC Form 4: Kramer Robin covered exercise/tax liability with 171 shares and converted options into 275 shares, increasing direct ownership by 8% to 1,458 units (withholding tax)Form 4Shares withheld for taxes or exercise priceOther acquisition or dispositionExercise or conversion of a derivative
- Feb 10, 2022BIIBSEC Form 4 filed by Kramer RobinForm 4Grant or award
- Jan 19, 2022BIIBSEC Form 4: Kramer Robin was granted 244 shares, increasing direct ownership by 22% to 1,354 unitsForm 4Grant or award
- Dec 8, 2021BIIBSEC Form 4 filed by Kramer RobinForm 4Grant or award
- Dec 3, 2021BIIBSEC Form 4: Kramer Robin exercised 339 shares at a strike of $223.92 and covered exercise/tax liability with 100 shares, increasing direct ownership by 27% to 1,110 unitsForm 4Shares withheld for taxes or exercise priceOther acquisition or dispositionExercise or conversion of a derivative
- Jul 1, 2021BIIBSEC Form 4: Kramer Robin exercised 251 units of Common Stock at a strike of $348.92 and covered exercise/tax liability with 74 units of Common Stock, increasing direct ownership by 25% to 871 unitsForm 4Shares withheld for taxes or exercise priceExercise or conversion of a derivative
- Jun 7, 2021ARMPSEC Form 4 filed by Kramer RobinForm 4Grant or award
- Feb 18, 2021BIIBSEC Form 4 filed by Robin KramerForm 4Grant or award
- Feb 12, 2021BIIBSEC Form 4: Robin Kramer exercised 333 units of Common Stock at a strike of $0.00 and disposed of $31,973 worth of Common Stock (115 units at $278.03), increasing ownership by 58% to 591 unitsForm 4Shares withheld for taxes or exercise priceOther acquisition or dispositionExercise or conversion of a derivative
Compare Robin Kramer with
- Robin Kramer vs Jane Grogan1 shared
- Robin Kramer vs Michael Parini1 shared
- Robin Kramer vs Lloyd Minor1 shared
- Robin Kramer vs Deborah Birx1 shared
- Robin Kramer vs William A Hawkins1 shared
- Robin Kramer vs Stephen A Sherwin1 shared
Other insiders at the same companies
- Jane GroganBIIB
- Michael PariniBIIB
- Lloyd MinorBIIB
- Deborah BirxARMP
- William A HawkinsBIIB
- Stephen A SherwinBIIB
- Eric K RowinskyBIIB
- Jesus B MantasBIIB
- Susan LangerBIIB
- Monish D PatolawalaBIIB
- Menelas N PangalosBIIB
- Maria C FreireBIIB
- Adam KeeneyBIIB
- Daniel B. GilmerARMP
- Sean GodboutBIIB
- Pierre KymeARMP
Questions about Robin Kramer
- What is Robin Kramer's role at Biogen Inc.?
- Robin Kramer reports to the SEC as chief Financial Officer at Biogen Inc. (BIIB), according to the latest filing on February 18, 2026. Robin Kramer has also filed as director at Armata Pharmaceuticals, Inc. (ARMP).
- How many shares does Robin Kramer own?
- After the latest filing that states it, Robin Kramer directly owned 11,472 shares of Biogen Inc. (BIIB). Shares held through trusts, funds or family members are reported separately and are not counted here.
- Has Robin Kramer bought or sold stock recently?
- No open-market purchases or sales by Robin Kramer are on file. The filings report grant or award, shares withheld for taxes or exercise price, exercise or conversion of a derivative and other acquisition or disposition.
- How do I get alerts when Robin Kramer files?
- Follow Robin Kramer on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.
From SEC Forms 3, 4, 5 and 144 filed by Robin Kramer (SEC CIK 0001609222). Totals count each trade once, skipping amendments whose original is on file, from Feb 17, 2021 on. View on SEC EDGAR